Summer School Molecular Pathology 2025

Advancing Precision in Urothelial Cancer Care

Molecular pathology is transforming diagnostic workflows, especially in oncology. With the rise of targeted therapies for urothelial carcinoma, the need for precise biomarker testing is more urgent than ever.

FGFR gene alterations — including somatic mutations and gene fusions — are key to identifying patients who may benefit from newly approved treatments.

We’re proud to support this year’s Summer School Molecular Pathology, a hands-on, practice-oriented training led by Prof. Schildhaus, Head of Molecular Pathology Nordhessen. This initiative fosters knowledge exchange and empowers professionals in molecular diagnostics.

Sabine Kießling-Parr will present Biotype’s robust FGFR testing solutions, designed to enable fast and accurate patient stratification in bladder cancer care.

Let’s connect during the workshop or contact us via our webpage form.